Chondroitin Sulfate Market Report by Source (Bovine, Swine, Poultry, Shark, and Others), Form (Powder, Tablet, and Others), Application (Pharmaceuticals and Nutraceuticals, Animal Feed, Personal Care and Cosmetics, and Others), and Region 2024-2032
Description
Chondroitin Sulfate Market Report by Source (Bovine, Swine, Poultry, Shark, and Others), Form (Powder, Tablet, and Others), Application (Pharmaceuticals and Nutraceuticals, Animal Feed, Personal Care and Cosmetics, and Others), and Region 2024-2032
The global chondroitin sulfate market size reached US$ 1.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.1 Billion by 2032, exhibiting a growth rate (CAGR) of 3.2% during 2024-2032.
Chondroitin sulfate (CS) is a water-soluble polymer comprising alternating N-Acetylgalactosamine and glucuronic acid, which is naturally found in the cartilage, bone and cornea of animals. CS (C6H13NO5) is anti-atherogenic, inflammatory, thrombogenic and assists in the performance of coagulant activities. Consequently, it is utilized in oral delivery of insulin, proteins and peptides and as a skin substitute and biomaterial for wound healing in the healthcare sector.
CS acts as a precursor for inhibiting degradation, stimulating synthesis and improving the healing of articular cartilage. This represents one of the primary factors escalating the demand for CS-based injectable hydrogels in cartilage tissue engineering for fabricating purposes. Moreover, as it is an enzymatically biodegradable polysaccharide and has high water solubility and lack of mechanical stability, CS is modified with materials like collagen to be utilized in scaffold matrices and other drug delivery applications. Furthermore, it is being used in dietary supplements for relieving pain and disability of individuals with musculoskeletal pathologies or osteoarthritis. In line with this, CS serves as a template for generating hydroxyapatite nanocrystals, thereby contributing to the market growth. It is also gaining traction as an antistatic agent in the cosmetics industry for manufacturing hair conditioning products.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global chondroitin sulfate market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on source, form and application.
Breakup by Source:
- Bovine
- Swine
- Poultry
- Shark
- Others
- Powder
- Tablet
- Others
- Pharmaceuticals and Nutraceuticals
- Animal Feed
- Personal Care and Cosmetics
- Others
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Bioiberica S.A.U., BRF S.A., HeBei SanXin Industrial Group, Maypro Industries Inc., Merck KGaA, Pacific Rainbow International Inc., Qingdao Wantuming Biological Products Co. Ltd., Seikagaku Corporation, Sino Siam Biotechnique Company Limited, Sioux Pharm Inc., Synutra International Inc. and ZPD A/S.
Key Questions Answered in This Report:
- How has the global chondroitin sulfate market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global chondroitin sulfate market?
- What are the key regional markets?
- What is the breakup of the market based on the source?
- What is the breakup of the market based on the form?
- What is the breakup of the market based on the application?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global chondroitin sulfate market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
141 Pages
- 1 Preface
- 2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
- 3 Executive Summary
- 4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
- 5 Global Chondroitin Sulfate Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
- 6 Market Breakup by Source
- 6.1 Bovine
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Swine
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Poultry
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Shark
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Others
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
- 7 Market Breakup by Form
- 7.1 Powder
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Tablet
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Others
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 8 Market Breakup by Application
- 8.1 Pharmaceuticals and Nutraceuticals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Animal Feed
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Personal Care and Cosmetics
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
- 10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
- 11 Value Chain Analysis
- 12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
- 13 Price Analysis
- 14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Bioiberica S.A.U.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.2 BRF S.A.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 HeBei SanXin Industrial Group
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 Maypro Industries Inc.
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.5 Merck KGaA
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Pacific Rainbow International Inc.
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.7 Qingdao Wantuming Biological Products Co. Ltd.
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.8 Seikagaku Corporation
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.9 Sino Siam Biotechnique Company Limited
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.10 Sioux Pharm Inc.
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.11 Synutra International Inc.
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.12 ZPD A/S
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
